Old Web
English
Sign In
Acemap
>
Paper
>
IGF-I response to pasireotide LAR treatment in acromegaly is mainly driven by somatostatin receptor subtype 2 expression
IGF-I response to pasireotide LAR treatment in acromegaly is mainly driven by somatostatin receptor subtype 2 expression
2018
Ammar Muhammad
Eva C Coopmans
Federico Gatto
Sanne Franck
J. A. M. J. L. Janssen
der Lelij Aart Jan van
Leo J Hofland
Sebastian Neggers
Keywords:
Pasireotide
Acromegaly
Endocrinology
Somatostatin receptor
Internal medicine
Biology
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]